Cancer Family
Esophageal Neoplasm
CI-CAN-00000174Explore in graph →
Non-malignant555 active trials6 approved drugs12 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000174Explore in graph →
Clinical trials
2,208 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03962179 | Feasibility and Efficacy of a Combination of a SEMS and Vacuum Wound Treatment (VACStent)(VACStent) | unknown | N/A | 20 | University Hospital of CologneOTHER | 1 | Aug 5, 2021 | clinicaltrials |
| NCT04984018 | Chidamide Plus Camrelizumab as Second-line Therapy for Advanced ESCC Treated With PD-1 Blockade | unknown | Phase 2 | 73 | The First Affiliated Hospital of Zhengzhou UniversityOTHER | 0 | Jul 30, 2021 |
| clinicaltrials |
| NCT04984096 | Anlotinib Combined With PD-1 Inhibitors for Advanced/Metastatic Esophageal Cancer(APEC) | unknown | — | 50 | Shanghai Chest HospitalOTHER | 0 | Jul 30, 2021 | clinicaltrials |
| NCT04966611 | Anlotinib for Esophageal Cancer (AFEC) | unknown | — | 200 | Anyang Tumor HospitalOTHER | 1 | Jul 19, 2021 | clinicaltrials |
| NCT04880811 | Afatinib Plus Toripalimab in Previously Treated ESCC With EGFR Overexpression or EGFR Amplification | unknown | Phase 2 | 43 | Peking UniversityOTHER | 1 | Jul 13, 2021 | clinicaltrials |
| NCT03766178 | Study of Anti-PD-1 Antibody SHR-1210 Plus Nimotuzumab in the Treatment of Advanced Esophageal Squamous Cell Carcinoma | unknown | Phase 2 | 45 | The First Affiliated Hospital of Zhengzhou UniversityOTHER | 1 | Jul 7, 2021 | clinicaltrials |
| NCT04275986 | Concurrent Chemoradiotherapy After Endoscopic Resection for Stage I Esophageal Carcinoma | unknown | Phase 2 | 56 | Chinese Academy of Medical SciencesOTHER | 1 | Jul 7, 2021 | clinicaltrials |
| NCT03713749 | Robotic-assisted Esophagectomy vs. Video-Assisted Thoracoscopic Esophagectomy(REVATE) Trial | unknown | N/A | 212 | Chang Gung Memorial HospitalOTHER | 1 | Jul 1, 2021 | clinicaltrials |
| NCT04851132 | Radiotherapy Plus Durvalumab in Elderly Esophageal Squamous Cell Carcinoma | unknown | N/A | 33 | Chinese Academy of Medical SciencesOTHER | 1 | Jun 22, 2021 | clinicaltrials |
| NCT04894149 | Prehabilitation and Rehabilitation for Patients With Oesophageal Cancer(PRESO) | unknown | N/A | 25 | Gabriella Alexandersson von DöbelnOTHER | 1 | May 20, 2021 | clinicaltrials |
| NCT04866381 | An Exploratory Clinical Study of SHR6390 and SHR1020 in the Treatment of Esophageal Squamous Cell Carcinoma After Progression on PD-1 Antibody | unknown | Phase 2 | 87 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Apr 29, 2021 | clinicaltrials |
| NCT04843397 | Diagnostic Performance Indicators in Upper GI Endoscopy:PROSPERO Study(PROSPERO) | unknown | — | 1,000 | University of CambridgeOTHER | 0 | Apr 15, 2021 | clinicaltrials |
| NCT03585530 | Raltitrexed Concurrent With Radiotherapy for Elderly Chinese Patients With Squamous Cell Carcinoma of Esophagus | unknown | Phase 2 | 32 | Huai'an First People's HospitalOTHER | 1 | Apr 6, 2021 | clinicaltrials |
| NCT04818476 | Outcomes of Endoscopically Resected High-risk Mucosal and Low- and High-risk Submucosal Adenocarcinoma Arising in Barrett's Esophagus | unknown | — | 1,000 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 7 | Mar 26, 2021 | clinicaltrials |
| NCT04813406 | Study of Anlotinib Plus Sintilimab in the Treatment of Advanced Esophageal Squamous Cell Carcinoma | unknown | N/A | 53 | Henan Provincial People's HospitalOTHER | 0 | Mar 24, 2021 | clinicaltrials |
| NCT03619317 | Impact of Cancer Therapy on Myocardial Function in Patients With Esophagus Cancer(Heartcheck) | unknown | — | 56 | Aarhus University Hospital SkejbyOTHER | 1 | Mar 23, 2021 | clinicaltrials |
| NCT03791905 | PET Imaging-guided Chemoradiotherapy in Esophageal Squamous Cell Carcinoma | unknown | Phase 2 | 216 | Mian XIOTHER | 1 | Mar 23, 2021 | clinicaltrials |
| NCT03535207 | High-dose Intensity Modulated Radiotherapy and Concurrent Chemotherapy in Esophageal Cancer | unknown | N/A | 50 | Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Mar 18, 2021 | clinicaltrials |
| NCT03936179 | High Dose PET/CT-guided Intensity Modulated Radiotherapy and Concurrent Chemotherapy in Esophageal Cancer | unknown | N/A | 50 | Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Mar 18, 2021 | clinicaltrials |
| NCT04804410 | Dielectric Properties of Matched Tissue Samples From Thoracic Malignancies and Corresponding Normal Tissues | unknown | N/A | 30 | University of Maryland, BaltimoreOTHER | 0 | Mar 18, 2021 | clinicaltrials |
| NCT04797507 | SHR-1210 in Combination With Anlotinib in Patients With Advanced or Metastatic Esophageal Squamous Cell Cancer | unknown | Phase 2 | 33 | Peking Union Medical College HospitalOTHER | 0 | Mar 15, 2021 | clinicaltrials |
| NCT04767295 | A Study of Camrelizumab Combined With Chemotherapy as Neoadjuvant Therapy in Adcanced Esophageal Squamous Cell Carcinoma (ESCC) | unknown | Phase 2 | 28 | Hunan Cancer HospitalOTHER | 1 | Feb 23, 2021 | clinicaltrials |
| NCT04759235 | Multimodal Functional Imaging Combined With Metabolomics in Predicting the Efficacy of nCRT for Locally Advanced ESCC | unknown | — | 118 | RenJi HospitalOTHER | 1 | Feb 18, 2021 | clinicaltrials |
| NCT04741490 | Camrelizumab Combined With Radiotherapy for Adjuvant Treatment of Esophageal Squamous Cell Carcinoma After Surgery | unknown | N/A | 20 | Fuzhou General HospitalOTHER | 1 | Feb 5, 2021 | clinicaltrials |
| NCT04514822 | Quantitative Evaluation of Metastatic Lymph Nodes With Dynamic 18F-FDG PET/CT in Patients With ESCC | unknown | N/A | 40 | Fifth Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Feb 4, 2021 | clinicaltrials |
| NCT04014465 | Monitoring Efficacy of Radiotherapy in Lung Cancer and Esophageal Cancer | unknown | — | 150 | Chinese Academy of Medical SciencesOTHER | 1 | Feb 2, 2021 | clinicaltrials |
| NCT04694391 | Genomic Study of Relapse Esophageal Cancer After Radiotherapy | unknown | — | 200 | Fudan UniversityOTHER | 1 | Jan 26, 2021 | clinicaltrials |
| NCT03377400 | Definitive CCRT Combined With Durvalumab and Tremelimumab for Inoperable Esophageal Cancer | unknown | Phase 2 | 40 | Samsung Medical CenterOTHER | 1 | Dec 17, 2020 | clinicaltrials |
| NCT03987815 | Neoadjuvant Nivolumab for Operable Esophageal Carcinoma | unknown | Phase 2 | 20 | Samsung Medical CenterOTHER | 1 | Dec 17, 2020 | clinicaltrials |
| NCT03896958 | The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)(PIONEER) | unknown | — | 1,000 | SpeciCareINDUSTRY | 1 | Dec 4, 2020 | clinicaltrials |
| NCT04648917 | GASC1 Inhibitor Caffeic Acid for Squamous Esophageal Cell Cancer (ESCC)(GiCAEC) | unknown | Phase 3 | 80 | The First Affiliated Hospital of Henan University of Science and TechnologyOTHER | 1 | Dec 3, 2020 | clinicaltrials |
| NCT03070262 | The Efficacy and Safety of Caffeic Acid for Esophageal Cancer(CAEC) | unknown | Phase 3 | 300 | The First Affiliated Hospital of Henan University of Science and TechnologyOTHER | 1 | Nov 27, 2020 | clinicaltrials |
| NCT04644250 | Combination of Toripalimab and Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma | unknown | Phase 2 | 32 | Wei RenOTHER | 1 | Nov 25, 2020 | clinicaltrials |
| NCT03474341 | Preoperative Image-guided Identification of Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer(PRIDE) | unknown | — | 200 | UMC UtrechtOTHER | 1 | Nov 16, 2020 | clinicaltrials |
| NCT03646110 | The Comparison of Single and Multi-incision MIE for Esophageal Cancer | unknown | N/A | 100 | National Taiwan University HospitalOTHER | 1 | Nov 5, 2020 | clinicaltrials |
| NCT04602013 | Sintilimab Injection Combined With Concurrent CCRT in Locally Advanced Esophageal Squamous Cell Carcinoma | unknown | Phase 2 | 53 | Sichuan Cancer Hospital and Research InstituteOTHER | 1 | Oct 26, 2020 | clinicaltrials |
| NCT03727126 | Robotic Versus Thoracolaparoscopic Esophagectomy for Esophageal Cancer | unknown | N/A | 40 | GEM Hospital & Research CenterOTHER | 1 | Oct 14, 2020 | clinicaltrials |
| NCT04481100 | CCRT With Itraconazole in Locally Advanced Squamous Esophageal Cancer | unknown | Phase 2 | 38 | Hangzhou Cancer HospitalOTHER | 1 | Oct 14, 2020 | clinicaltrials |
| NCT04576858 | Clinical Utility of Circulating Tumor DNA in Gastro-Esophageal Cancer(CURE) | unknown | — | 1,950 | Rigshospitalet, DenmarkOTHER | 1 | Oct 6, 2020 | clinicaltrials |
| NCT04484311 | Non-curative ESDs: Assessing the Rates and Risk Factors for Residual Neoplasia(NC-ESD) | unknown | — | 300 | Universidade do PortoOTHER | 1 | Sep 23, 2020 | clinicaltrials |
| NCT04517019 | Randomised Trial Evaluating the Benefit of a Fitness Tracker Based Workout During Radiotherapy(OnkoFit II) | unknown | N/A | 201 | University Hospital TuebingenOTHER | 1 | Aug 18, 2020 | clinicaltrials |
| NCT04512417 | A Clinical Study Of Camrelizumab With Or Without Radiotherapy In The Treatment Of Esophageal Cancer | unknown | Phase 2 | 63 | Zhejiang Cancer HospitalOTHER | 1 | Aug 13, 2020 | clinicaltrials |
| NCT04503967 | Efficacy and Safety of Anlotinib Hydrochloride Combined With Nivolumab in the Treatment of Gastric and Esophageal Cancer(OASIS) | unknown | Phase 2 | 48 | Shanghai Zhongshan HospitalOTHER | 0 | Aug 7, 2020 | clinicaltrials |
| NCT04504565 | 99m Tc-3PRGD2 SPECT/CT Imaging in the Diagnosis of Lymph Node Metastasis of Esophageal Carcinoma | unknown | N/A | 30 | Fifth Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Aug 7, 2020 | clinicaltrials |
| NCT03507998 | Phase 1 Dose Escalation Study of CGX1321 in Subjects With Advanced Gastrointestinal Tumors | unknown | Phase 1 | 39 | Curegenix Inc.INDUSTRY | 1 | Jul 24, 2020 | clinicaltrials |
| NCT03734926 | A Phase 1 Study of ZSP1241 in Participants With Advanced Solid Tumors | unknown | Phase 1 | 90 | Guangdong Zhongsheng Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 22, 2020 | clinicaltrials |
| NCT04466631 | Health and Employment After Gastro Intestinal Surgery - HEAGIS2(HEAGIS2) | unknown | — | 50 | University of PadovaOTHER | 1 | Jul 10, 2020 | clinicaltrials |
| NCT04437212 | Neoadjuvant Chemoradiotherapy Combined With Perioperative Toripalimab in Locally Advanced Esophageal Cancer | unknown | Phase 2 | 20 | RenJi HospitalOTHER | 1 | Jun 26, 2020 | clinicaltrials |
| NCT04440332 | Surveillance of Peripheral Blood of Lymphocyte and Immunocyte in Neoadjuvant Therapy Patients With Esophageal Squamous Cell Carcinoma (pLINE) | unknown | — | 138 | Sichuan Cancer Hospital and Research InstituteOTHER | 1 | Jun 19, 2020 | clinicaltrials |
| NCT04229524 | Quantitative Assessment of Blood Supply in the Gastic Conduit With Fluorescence Angiography for Esophageal Reconstruction | unknown | N/A | 246 | Sichuan Cancer Hospital and Research InstituteOTHER | 1 | Jun 9, 2020 | clinicaltrials |
Data updated 23 days agoSource updated Aug 5, 2021source: clinicaltrials